Notification pursuant to List

RNS Number : 5226S
GlaxoSmithKline PLC
10 September 2010
 



Directorate Change

 

Further to the announcement made on 8 September 2010 regarding the appointment of Simon Dingemans as Executive Director and Chief Financial Officer Designate with effect from 4 January 2011, the Company confirms that there are no further disclosures to be made in accordance with Listing Rule 9.6.13R.

 

S M Bicknell

Company Secretary

 

10 September 2010


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNSFSFISFSSESU

Companies

GSK (GSK)
UK 100

Latest directors dealings